Citadel Advisors’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-38,973
Closed -$88.5K 5982
2024
Q1
$88.5K Buy
+38,973
New +$88.5K ﹤0.01% 5124
2023
Q1
Sell
-1,102
Closed -$13.4K 5961
2022
Q4
$13.4K Sell
1,102
-53
-5% -$646 ﹤0.01% 5628
2022
Q3
$10K Buy
+1,155
New +$10K ﹤0.01% 5642
2022
Q2
Sell
-5,519
Closed -$67K 6067
2022
Q1
$67K Sell
5,519
-28,806
-84% -$350K ﹤0.01% 5809
2021
Q4
$560K Buy
34,325
+13,819
+67% +$225K ﹤0.01% 4469
2021
Q3
$325K Buy
20,506
+16,555
+419% +$262K ﹤0.01% 4956
2021
Q2
$365K Sell
3,951
-11,468
-74% -$1.06M ﹤0.01% 5016
2021
Q1
$802K Buy
15,419
+12,329
+399% +$641K ﹤0.01% 4140
2020
Q4
$83K Sell
3,090
-3,564
-54% -$95.7K ﹤0.01% 4735
2020
Q3
$187K Buy
6,654
+2,116
+47% +$59.5K ﹤0.01% 4113
2020
Q2
$65K Buy
4,538
+503
+12% +$7.21K ﹤0.01% 4315
2020
Q1
$45K Sell
4,035
-909
-18% -$10.1K ﹤0.01% 4558
2019
Q4
$103K Buy
4,944
+3,858
+355% +$80.4K ﹤0.01% 4282
2019
Q3
$25K Sell
1,086
-1,393
-56% -$32.1K ﹤0.01% 4476
2019
Q2
$74K Buy
2,479
+1,677
+209% +$50.1K ﹤0.01% 4300
2019
Q1
$17K Sell
802
-1,276
-61% -$27K ﹤0.01% 4415
2018
Q4
$59K Buy
2,078
+1,198
+136% +$34K ﹤0.01% 4087
2018
Q3
$38K Sell
880
-1,403
-61% -$60.6K ﹤0.01% 4033
2018
Q2
$89K Buy
+2,283
New +$89K ﹤0.01% 3852
2018
Q1
Sell
-769
Closed -$12K 3998
2017
Q4
$12K Sell
769
-368
-32% -$5.74K ﹤0.01% 3807
2017
Q3
$36K Buy
+1,137
New +$36K ﹤0.01% 3443
2017
Q2
Sell
-1,480
Closed -$65K 3680
2017
Q1
$65K Buy
+1,480
New +$65K ﹤0.01% 3374
2016
Q4
Sell
-553
Closed -$31K 3608
2016
Q3
$31K Buy
+553
New +$31K ﹤0.01% 3354